Komori
Statutory disclosure document2689OLBA DVx HEALTHCARE,Inc.Trading & Wholesale

Statutory Prior Disclosure Document (Share Exchange) (DVx Inc.)

OLBA HEALTHCARE HOLDINGS has decided to conduct a share exchange under which DVx Inc. will become its wholly owned subsidiary, scheduled for 1 September 2026. DVx Inc. shareholders will receive 0.50 shares of OLBA HEALTHCARE HOLDINGS for each DVx Inc. share they hold.

Worth reading
74In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
5183078
Number of shares scheduled to be issued
Wording
Conditional
How definitive the wording is.

Decision and Details

The boards of directors of both companies

A share exchange under which the Company will become the wholly owning parent company and DVx Inc. will become the wholly owned subsidiary

Decision22 May 2026
Period CoveredThe period for carrying out the share exchange procedures from the effective date until DVx Inc. becomes a wholly owned subsidiary of OLBA HEALTHCARE HOLDINGS
Implementation1 September 2026 (scheduled; subject to change as necessary)
Going forwardThe two companies will convene shareholder meetings by the day before the effective date and seek approval of this agreement and other matters. DVx Inc. plans to cancel its treasury shares by the day before the effective date. The final trading date is scheduled for 27 August 2026, the delisting for 28 August 2026 and the share exchange taking effect on 1 September 2026.
AmountIncrease in the stated capital of the wholly owning parent company: ¥0; increase in legal capital surplus: ¥0; DVx Inc. dividends of surplus: ¥525,047,800; OLBA HEALTHCARE HOLDINGS dividends of surplus: ¥494,378,240
Quantity / scaleShare exchange ratio: 0.50 shares of OLBA HEALTHCARE HOLDINGS common stock for each share of DVx Inc. common stock; number of shares scheduled to be issued: 5,183,078 shares; final trading date for DVx Inc. shares: 27 August 2026; delisting date: 28 August 2026
Reason

The purpose is to integrate the management of the two companies on an equal footing. Based on the calculations by independent valuation institutions, advice from legal advisers and the results of due diligence, the companies determined that the share exchange ratio was appropriate and would serve the interests of their respective shareholders.

Impact on Business Performance

These documents do not state the specific amount of the impact of the share exchange on business performance.

Decision and Details
ItemDetails
Matter CoveredA share exchange under which the Company will become the wholly owning parent company and DVx Inc. will become the wholly owned subsidiary
Decision-Making BodyThe boards of directors of both companies
Decision Date22 May 2026
Implementation Date1 September 2026 (scheduled; subject to change as necessary)
Period CoveredThe period for carrying out the share exchange procedures from the effective date until DVx Inc. becomes a wholly owned subsidiary of OLBA HEALTHCARE HOLDINGS
AmountIncrease in the stated capital of the wholly owning parent company: ¥0; increase in legal capital surplus: ¥0; DVx Inc. dividends of surplus: ¥525,047,800; OLBA HEALTHCARE HOLDINGS dividends of surplus: ¥494,378,240
Quantity / scaleShare exchange ratio: 0.50 shares of OLBA HEALTHCARE HOLDINGS common stock for each share of DVx Inc. common stock; number of shares scheduled to be issued: 5,183,078 shares; final trading date for DVx Inc. shares: 27 August 2026; delisting date: 28 August 2026
Impact on Business PerformanceThese documents do not state the specific amount of the impact of the share exchange on business performance.
ReasonThe purpose is to integrate the management of the two companies on an equal footing. Based on the calculations by independent valuation institutions, advice from legal advisers and the results of due diligence, the companies determined that the share exchange ratio was appropriate and would serve the interests of their respective shareholders.
Governing RuleArticle 794, paragraph 1 of the Companies Act; Article 193 of the Ordinance for Enforcement of the Companies Act; Article 768, paragraph 1, Article 234, Article 785, paragraph 1 and Article 459, paragraph 1 of the Companies Act
Future plansThe two companies will convene shareholder meetings by the day before the effective date and seek approval of this agreement and other matters. DVx Inc. plans to cancel its treasury shares by the day before the effective date. The final trading date is scheduled for 27 August 2026, the delisting for 28 August 2026 and the share exchange taking effect on 1 September 2026.
Items this document does not state (1)
Related previous disclosures

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The purpose is to integrate the management of the two companies on an equal footing. The companies state that, based on the calculations by independent valuation institutions, advice from legal advisers and the results of due diligence, they determined that the share exchange ratio was appropriate and would serve the interests of their respective shareholders.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Statutory Prior Disclosure Document (Share Exchange) (DVx Inc.) | OLBA DVx HEALTHCARE,Inc. (2689) timely disclosure | Komori